ATE469643T1 - Mit gesättigten o-heterocyclen substituierte alkansäureamide - Google Patents

Mit gesättigten o-heterocyclen substituierte alkansäureamide

Info

Publication number
ATE469643T1
ATE469643T1 AT06778437T AT06778437T ATE469643T1 AT E469643 T1 ATE469643 T1 AT E469643T1 AT 06778437 T AT06778437 T AT 06778437T AT 06778437 T AT06778437 T AT 06778437T AT E469643 T1 ATE469643 T1 AT E469643T1
Authority
AT
Austria
Prior art keywords
heterocycles
saturated
acid amides
alkanoic acid
amides substituted
Prior art date
Application number
AT06778437T
Other languages
English (en)
Inventor
Peter Herold
Robert Mah
Vincenzo Tschinke
Stefan Stutz
Aleksandar Stojanovic
Stjepan Jelakovic
Christiane Marti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE469643T1 publication Critical patent/ATE469643T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT06778437T 2005-09-17 2006-09-14 Mit gesättigten o-heterocyclen substituierte alkansäureamide ATE469643T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH15182005 2005-09-17
PCT/EP2006/066368 WO2007031557A2 (en) 2005-09-17 2006-09-14 Alcanoic acid amides substituted by saturated o-heterocycles

Publications (1)

Publication Number Publication Date
ATE469643T1 true ATE469643T1 (de) 2010-06-15

Family

ID=37847050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778437T ATE469643T1 (de) 2005-09-17 2006-09-14 Mit gesättigten o-heterocyclen substituierte alkansäureamide

Country Status (15)

Country Link
US (2) US8058307B2 (de)
EP (1) EP1937248B1 (de)
JP (1) JP2009507899A (de)
CN (1) CN101262864A (de)
AR (1) AR057816A1 (de)
AT (1) ATE469643T1 (de)
BR (1) BRPI0616219A2 (de)
CA (1) CA2622375A1 (de)
DE (1) DE602006014707D1 (de)
ES (1) ES2346081T3 (de)
IL (1) IL190060A0 (de)
PL (1) PL1937248T3 (de)
PT (1) PT1937248E (de)
TW (1) TW200804330A (de)
WO (1) WO2007031557A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006095020A1 (en) * 2005-03-11 2006-09-14 Speedel Experimenta Ag Heterocyclic-substituted alkanamides useful as renin inhibitors
JP5306821B2 (ja) 2005-12-30 2013-10-02 ノバルティス アーゲー レニン阻害剤としての３，５−置換ピペリジン化合物
EP1958666A1 (de) * 2007-02-13 2008-08-20 Speedel Experimenta AG Heterozyklische substituierte Alkanamide als therapeutische Verbindungen
EP2527338B1 (de) 2007-06-25 2015-05-06 Novartis AG N5-(2-ethoxyethyl)-n3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivate als renin inhibitoren
US8968362B2 (en) * 2010-04-08 2015-03-03 Covidien Lp Coated looped suture
US20140288169A1 (en) * 2011-01-07 2014-09-25 Targacept, Inc. Nicotinic receptor non-competitive antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
EP2266951A1 (de) * 2003-11-26 2010-12-29 Novartis AG Organische Verbindungen
TW200633983A (en) 2004-12-10 2006-10-01 Speedel Experimenta Ag 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-nonanamides
WO2006095020A1 (en) * 2005-03-11 2006-09-14 Speedel Experimenta Ag Heterocyclic-substituted alkanamides useful as renin inhibitors

Also Published As

Publication number Publication date
EP1937248A2 (de) 2008-07-02
AR057816A1 (es) 2007-12-19
WO2007031557A3 (en) 2007-05-24
IL190060A0 (en) 2008-12-29
WO2007031557A2 (en) 2007-03-22
DE602006014707D1 (de) 2010-07-15
BRPI0616219A2 (pt) 2011-06-14
US8058307B2 (en) 2011-11-15
ES2346081T3 (es) 2010-10-08
US20090275651A1 (en) 2009-11-05
EP1937248B1 (de) 2010-06-02
CA2622375A1 (en) 2007-03-22
US20110144197A1 (en) 2011-06-16
JP2009507899A (ja) 2009-02-26
PT1937248E (pt) 2010-07-06
TW200804330A (en) 2008-01-16
PL1937248T3 (pl) 2010-11-30
CN101262864A (zh) 2008-09-10

Similar Documents

Publication Publication Date Title
FR22C1054I2 (fr) Amides peptidiques synthetiques
CY2021030I2 (el) Νεο οξινο θειικο αλας
LTC1912503I2 (lt) Fungicidiniai mišiniai, turintys 1-metilpirazol-4-ilo karboksirūgšties anilidus
ATE482185T1 (de) Heteroaroylsubstituierte serin-amide
ATE509925T1 (de) Substituierte bicyclocarbonsäureamidverbindungen
ATE408608T1 (de) Benzoylsubstituierte serin-amide
DE602007009238D1 (de) Biplanare elektrode mit sperr-gates
EP1886150A4 (de) Stromsensor
DK1989192T3 (da) 1,3-dioxane carboxylsyrer
SI1771441T1 (sl) Novi amidi karboksilnih kislin kot inhibitorji faktorja XA
DE502005005266D1 (de) Dosierpumpe
DE602005027905D1 (de) Nmr-rf-spulen mit verbessertem niederfrequenz-wirkungsgrad
DE602006018127D1 (de) Acetylenderivate
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
ITFI20050094A1 (it) Opercolatrice perfezionata
DE602006001073D1 (de) Viehmarke
IL190060A0 (en) Alcanoic acid amides substituted by saturated o-heterocycles
DE602006012689D1 (de) Überprüfungsverfahren
DE602005016309D1 (de) Laas-bodeneinrichtungs-sigma-monitor
DE502006004614D1 (de) Fadenverbindungsvorrichtung
DE602006001668D1 (de) Fehlerüberprüfungsverfahren
ITMI20060151U1 (it) Moble
ES1060039Y (es) Mosquero perfeccionado
ATE420094T1 (de) Substituierte propanphosphinsäureester
SE0501975L (sv) Konstruktionsämne

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1937248

Country of ref document: EP